Bio-Path Holdings

-$0.07 (-2.16%) As of 5:27 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BPTH and other ETFs, options, and stocks.

About BPTH

Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1002, and BP1003.

CEO
Peter H. Nielsen
Employees
10
Headquarters
Bellaire, Texas
Founded
2007

BPTH Key Statistics

Market cap
22.70M
Price-Earnings ratio
—
Dividend yield
—
Average volume
37.30K
High today
$3.22
Low today
$3.08
Open price
$3.22
Volume
21.11K
52 Week high
$8.62
52 Week low
$2.68

BPTH Earnings

-$0.87
-$0.67
-$0.46
-$0.26
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.45 per share
Actual
-$0.47 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure